Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 23, 2005

View Archived Issues

Therapeutic benefits of an iron chelator for mucormycosis infection

Broad antifungal activity of T-23207 emerging from further preclinical studies

Nutra Pharma reports findings in MS

Tanox files IND for TNX-650 in Hodgkin's lymphoma

Enanta receives milestone for initiation of phase II trials in Japan for EDP-420

R-788 studied in rheumatoid arthritis patients in phase I

Rigel files IND for R-763

Phase IIb asthma study of IPL-512602 to begin Q1

Allergan and Inamed execute definitive merger agreement

Orphan drug designation for Prochymal in GVHD

New pharmacokinetic studies begin for controlled-release zileuton

Caprion's caStx1 and caStx2 antibodies designated orphan drugs

Gammacan enters research and licensing agreement with Tel Hashomer

Tanabe Seiyaku launches Mearubik combined vaccine for measles and rubella

Torsemide ER indicates better sodium excretion in CHF patients than immediate-release product

Several classes of lipids modulate tight junctions to enhance drug permeation

New data on BIA-2-093 presented at American epilepsy meeting

Novel compounds potentially for treatment of inflammatory disorders claimed in recent patents

Agents with possible use in respiratory diseases claimed

Recent Bayer patent discloses new Rho kinase inhibitors

A novel PI3K inhibitor studied for the treatment of Ph+ ALL, B-NHL and MM

Medivir updates business strategy

Otsuka presents elaborate data on OPC-67683

Tamiflu approved for prevention of influenza in children aged 1 to 12

NeuroSearch updates progress of NS-1209

Priority review for varenicline tartrate in smoking cessation

Novexel and sanofi-aventis present data on a novel oral streptogramin

Fast track designation for VX-950 in hepatitis C

New specific Arp2/3 complex inhibitors for the study of actin cytoskeleton dynamics

Studies assess in vitro and clinical activity of depsipeptide

Noscapine demonstrates promising activity in non-Hodgkin's lymphoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...